PhRMA Endorses Proposed AMP Rule In Principle But Perhaps Not In Practice

The Pharmaceutical Research and Manufacturers of America is supporting CMS' proposal to broadly define the "retail class of trade" for the purpose of calculating Medicaid average manufacturer prices, but raises concern about manufacturers' potential responsibility to track the various sales and price concessions through the drug distribution network